Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 11/20 | 0.38 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | TEAD4 | Q15561 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789434 | 1.00 | MAPKAPK2 (0.38) | MAPKAPK2CXCR2MAPK14TEAD4MEN1 | |
| Hydrochloric Acid SCHEMBL7803654 | 0.99 | MAPKAPK2 (0.37) | MAPKAPK2CXCR2MAPK14TEAD4MEN1 | |
| Hydrochloric Acid SCHEMBL7801963 | 0.99 | MAPKAPK2 (0.37) | MAPKAPK2CXCR2MAPK14TEAD4MEN1 | |
| SCHEMBL7785252 | 0.95 | MAPKAPK2 (0.40) | MAPKAPK2CXCR2MAPK14TEAD4PDPK1 | |
| Hydrochloric Acid SCHEMBL7785103 | 0.94 | MAPKAPK2 (0.40) | MAPKAPK2CXCR2MAPK14TEAD4PDPK1 | |
| SCHEMBL7801400 | 0.93 | S1PR3 (0.38) | MAPKAPK2CXCR2MAPK14MEN1KMT2A | |
| SCHEMBL7784941 | 0.93 | S1PR3 (0.38) | MAPKAPK2CXCR2MAPK14MEN1KMT2A | |
| SCHEMBL7785139 | 0.93 | S1PR3 (0.40) | MAPKAPK2CXCR2MAPK14TEAD4S1PR3 | |
| SCHEMBL7785672 | 0.92 | S1PR3 (0.39) | MAPKAPK2CXCR2MAPK14TEAD4S1PR3 | |
| Hydrochloric Acid SCHEMBL7801207 | 0.92 | S1PR3 (0.38) | MAPKAPK2CXCR2MAPK14MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6329405-B1 | AS ILEAL BILE ACID TRANSPORTER INHIBITOR, FOR THERAPY OF HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-1070703-A1 | Cyclobutene derivatives | Sankyo Company Limited (JP) | 2001-01-24 | — | — | EP | disclosed |